-
HOSPITALIZATION COSTS ASSOCIATED WITH 30-DAY UNPLANNED READMISSIONS AND POTENTIALLY PREVENTABLE READMISSIONS IN US OLDER PATIENTS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
Mar 18, 2026, 21:38 PM -
ASSESSING THE CONCORDANCE BETWEEN SELF-REPORTED NICOTINE PRODUCT USE AND EMR DIAGNOSIS CODES IN THE ALL OF US RESEARCH PROGRAM
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR MENTAL HEALTH DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COMPARING OUTCOME MODELING STRATEGIES FOR ZERO-INFLATED ABSENTEEISM IN REAL-WORLD DATA: IMPLICATIONS FOR INFERENCE ON ANXIETY SEVERITY
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC IMPACT ASSESSMENT OF HORMONAL IUD USE IN REDUCING UNPLANNED PREGNANCIES IN BRAZIL: REAL-WORLD ANALYSIS FROM A BRAZILIAN HEALTH INSURANCE COMPANY
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
BURDEN OF DISEASE AND PATIENT JOURNEY OF COPD IN BRAZIL: A REAL-WORLD EVIDENCE STUDY USING LINKED PUBLIC DATABASES
Mar 18, 2026, 21:38 PM -
EMBEDDED QUALITATIVE INTERVIEWS - GUIDANCE AND PRACTICE BY MAJOR HTA BODIES
Mar 18, 2026, 21:38 PM -
SLEEP AND PSYCHOLOGICAL WELL-BEING IN U.S. AND SOUTH KOREAN ADOLESCENTS
Mar 18, 2026, 21:38 PM -
THE IMPACT OF THE FIRST FAMILY CORONAVIRUS RESPONSE ACT ON HEALTHCARE SERVICE UTILIZATION AMONG MEDICAID BENEFICIARIES WITH SICKLE CELL DISEASE IN WISCONSIN
Mar 18, 2026, 21:38 PM -
TARGET POPULATION SIZE AND LAUNCH PRICE DYNAMICS OF CELL AND GENE THERAPIES (CGTS)
Mar 18, 2026, 21:38 PM -
WHAT'S IN AN ABSTRACT? PICOS REPORTING FREQUENCIES TO INFORM AI-ASSISTED SCREENING
Mar 18, 2026, 21:38 PM -
A MODULAR ONCOLOGY REFERENCE MODEL FOR EARLY ECONOMIC EVALUATION: A CASE STUDY IN EGFR-MUTATED NSCLC
Mar 18, 2026, 21:38 PM -
DEVELOPMENT AND VALIDATION OF A NOMOGRAM TO PREDICT OVERALL SURVIVAL IN NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
CONCOMITANT USE OF DPP4 INHIBITORS AND RAAS INHIBITORS AND RISK OF ANGIOEDEMA: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
THE ICEBERG STUDY: VALIDATING PATIENT RIGHT OF ACCESS DATA COLLECTION AS A NOVEL METHOD FOR LONGITUDINAL RWD GENERATION IN CLINICAL RESEARCH
Mar 18, 2026, 21:38 PM -
HEALTHCARE UTILIZATION AND COSTS ATTRIBUTABLE TO CLINICALLY IMPACTFUL IMMUNE-RELATED ADVERSE EVENTS AMONG OLDER ADULTS WITH ADVANCED NON-SMALL CELL LUNG CANCER TREATED WITH IMMUNE CHECKPOINT INHIBITORS
Mar 18, 2026, 21:38 PM -
FDA APPROVALS OF SPECIALTY DRUGS, 2000-2024
Mar 18, 2026, 21:38 PM -
ACCESS CHALLENGES IDENTIFIED BY WOMEN WITH CARDIOVASCULAR DISEASE: FINDINGS FROM THE SECOND PHASE OF THE PATIENT-LED INSIGHTS AND PATIENT EXPERIENCES WITH CARDIOVASCULAR DISEASE (IPEC2) INITIATIVE
Mar 18, 2026, 21:38 PM -
CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN CISPLATIN ELIGIBLE VERSUS CISPLATIN INELIGIBLE MUSCLE INVASIVE BLADDER CANCER PATIENTS WITH INTENT FOR RESECTION: A MULTICOUNTRY RETROSPECTIVE CHART REVIEW IN EUROPE
Mar 18, 2026, 21:38 PM
